UBS analyst Peter Grom lowered the firm’s price target on Edgewell Personal Care (EPC) to $21 from $28 and keeps a Neutral rating on the shares. Edgewell reported a “challenging” Q3 with guidance for fiscal 2025 moving lower, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care price target lowered to $32 from $35 at Canaccord
- Edgewell Personal Care: Hold Rating Amidst Valuation Challenges and Future Growth Pressures
- Edgewell upgraded to Equal Weight from Underweight at Morgan Stanley
- Edgewell Personal Care Reports Q3 2025 Earnings
- Edgewell Personal Care Co Faces Challenges Amid Growth